Kayla Jamieson
Family Medicine · Cape Girardeau, MONPI 1184211054
Payments from drug & device makers
Across 171 payments — averaging $17.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$581
- AstraZeneca$389
- Lundbeck LLC$190
- Lilly USA, LLC$72
- Johnson & Johnson$71
- plus $671 from 19 others
What the payments were for
- Food & beverage$3,023100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$3,023 in reported general payments places this provider in the 80th percentile of 2,203 family medicine providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RexultiBrexpiprazole | 34 | $56,406 |
| VraylarCariprazine Hcl | 31 | $56,150 |
| UbrelvyUbrogepant | 44 | $49,119 |
| OzempicSemaglutide | 50 | $47,570 |
| TrulicityDulaglutide | 45 | $43,600 |
| Invega SustennaPaliperidone Palmitate | 12 | $42,060 |
| JardianceEmpagliflozin | 57 | $41,378 |
| MounjaroTirzepatide | 39 | $40,661 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 50 | $32,383 |
| EliquisApixaban | 46 | $30,088 |
| JanuviaSitagliptin Phosphate | 31 | $24,411 |
| VascepaIcosapent Ethyl | 66 | $23,880 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 40 | $19,443 |
| FarxigaDapagliflozin Propanediol | 31 | $16,470 |
| LinzessLinaclotide | 27 | $14,414 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar, Ubrelvy, Linzess | $1,049 | $119,683102 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $72 | $84,26184 claims |
| Boehringer IngelheimJardiance, Combivent Respimat | $14 | $60,82197 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $68 | $56,40634 claims |
| Johnson & JohnsonInvega Sustenna, Xarelto | $71 | $49,85126 claims |
| AstraZenecaBreztri Aerosphere, Farxiga | $389 | $48,85381 claims |
| Novo NordiskOzempic | $53 | $47,57050 claims |
| PfizerEliquis | $15 | $30,08846 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Cape Girardeau
- Lori MoyersCape Girardeau$21K
- Christopher ComptonCape Girardeau$18K
- Timothy JenningsMaryland Heights$30.2M
- William HowittSpringfield$19.9M
- Rupal TrivediSaint Louis$10.6M
- Frederic PraterMaryland Heights$9.1M
- Leea ReedRogersville$7.9M
- Dennis MorrisonSpringfield$5.7M
- Luke van KirkSpringfield$5.6M
- Amy RobertsTown And Country$4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.